With proven capabilities in antibody discovery services, Creative Biolabs works to provide virology researchers with high quality ViroAntibodies and neutralization assay services to support research advancement.
New York, USA – July 21, 2022 – Antibody neutralization of viruses is a common medical phenomenon. Although neutralization is believed to have the ability to eliminate or reduce viral replication, it does not imply any specific mechanism of disruption of the replication process. Numerous antibody therapies based on neutralization mechanisms have currently been developed for the treatment of various infectious diseases, endocrine disorders and many others. The neutralization assay is now used specifically for routine validation and measurement of the therapeutic effect of such antibodies. Creative Biolabs’ viroantibody neutralization assay service promises customers the most reliable results and gives them complete confidence in their virology research.
As an artificially produced recombinant virus particle, the pseudovirus often has a similar conformation to a live virus and can mimic a viral infection. Pseudoviruses have become useful virological tools because of their safety and versatility, particularly for emerging and re-emerging viruses such as SARS-CoV-2. Based on the VSV pseudovirus production system, Creative Biolabs has developed a pseudovirus-based neutralization assay. In addition to the neutralization assay, neutralization antibody products are also supported to meet the study needs of customers worldwide.
The coxsackievirus belongs to the enterovirus family. Coxsackievirus B3 (CVB3) has been identified as an active pathogen in myocarditis, aseptic meningitis, hand, foot and mouth disease (HFMD) and pancreatitis and poses a significant public health burden. Currently, anti-coxsackievirus antibodies are widely recognized as essential Elements in diagnostic assays for…